CVS, Upbeat Q4

CVS wins upgrade to buy as analyst sees more upside potential than its peers
A Leerink analyst says CVS is starting to benefit from stabilization in its Aetna health-insurance and pharmacy-benefits businesses.
Top Analysts Upgrade CVS Health Stock (CVS) after Upbeat Q4 Results
CVS Health (CVS) stock soared about 15% yesterday after posting upbeat fourth-quarter results, with revenues and earnings surpassing analysts’
CVS Health Gains Momentum After Q4 Performance, Analyst Upgrades Stock
CVS Health exceeded Q4 sales estimates with $97.71B revenue. The company projects 2025 revenue above $134B and expects Medicare Advantage margins to improve.
CVS Health (NYSE:CVS) Upgraded at Leerink Partnrs
Leerink Partnrs upgraded shares of CVS Health (NYSE:CVS – Free Report) from a hold rating to a strong-buy rating in a research note published on Wednesday,Zacks.com reports. Leerink Partnrs also issued estimates for CVS Health’s FY2027 earnings at $8.
CVS Earnings: CVS Health Stock Jumps as Earnings Beat Despite Higher Insurance Payouts
Troubled drugstore chain CVS Health (CVS) reported Fiscal fourth-quarter results that beat on the top and bottom lines, sending shares sharply
CVS Health: Earnings Beat Ignites Stock Rally
Shares of CVS Health Corporation (NYSE: CVS) experienced a jolt, rising over 15% on February 12, 2025, as the market responded to the release of its fourth-quarter 2024 earnings report. CVS Health's stock price increase comes after a period of decline,
Leerink Partners Upgrades CVS Health (CVS)
Fintel reports that on February 13, 2025, Leerink Partners upgraded their outlook for CVS Health (NYSE:CVS) from Market Perform to Outperform. Analyst Price Forecast Suggests 3.67% Upside As of January 28,
CVS soars after fourth-quarter profit signals improvement
CVS is trying to turn around its drugstore chain and insurance business. The company spent a smaller percentage of premium ...
CVS Health steers through rising insurance costs in a strong fourth quarter
CVS Health’s adjusted fourth-quarter profit handily beat Wall Street’s estimates, even as the drugstore chain and pharmacy ...
Why CVS Stock Thrashed the Market on Thursday
For the second day in a row, CVS Health's (NYSE: CVS) stock price saw a satisfying jump on Thursday. It closed the day almost ...
CVS Health 2024 Profits Eclipse $4.6 Billion Despite Rising Costs
CVS Health reported $4.6 billion in 2024 profit including $1.6 billion in the fourth quarter as its health insurance business ...
CVS Stock Rallies After Company Offers Some Investor Assurance for 2025
CVS Health shares surged after it closed out a difficult year with earnings that beat Wall Street’s lowered expectations, and ...
FOX 5 Atlanta1d
CVS to close 270 more stores in 2025
CVS Pharmacy is continuing its nationwide store realignment, announcing plans to close an additional 270 locations this year ...
CVS Health beats quarterly profit estimates on lower medical costs
CVS Health reported a smaller-than-expected drop in fourth-quarter profit on Wednesday as the pace of medical cost increases ...
Five things: Biogen, CVS, Eastern Nazarene, spring training, Rat Day, and more Valentine’s ideas
Good morning, Boston. Spring training has begun, and here are the five things you need to know, including Biogen cutbacks, CVS's new CEO, Eastern Nazarene sale, spring training, Rat Day, and more Vale ...